Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Fill out both forms, then either email or fax them to us at the contact above.
Provider? Stay in the know
Get the newest information from the Immunization Program right in your inbox!
Sign upRSV Season Ends March 31 As the respiratory syncytial virus (RSV) season draws to a close on March 31, we want to remind all healthcare providers of important considerations regarding administering nirsevimab (Beyfortus) and RSV immunization. End of RSV season: The RSV season officially concludes on March...
Catch Up Pediatric Patients: MMR Vaccine There is a measles cluster in Philadelphia that started with an infant and spread to unvaccinated individuals. It has resulted in now 7 confirmed cases of measles among Philadelphia residents and an index case in Delaware county.To prevent further spread, review your...
Vaccine Product Available Through VFC: Abrysvo Abrysvo is a maternal RSV vaccine available through the Vaccines for Children (VFC) program. RSV is surging and the pediatric infant immunization Beyfortus supply is severely limited. Abrysvo will play an important role in protecting infants against severe RSV disease this season. Most...
New Immigrant and Refugee Pediatric Vaccination This blog post was written alongside Dr. Mayssa Abuali, who has served the Philadelphia pediatric community for the past 10 years. At the first domestic health visit with new immigrant or refugee pediatric patients, clinicians should review all available vaccine records,...
New Meningococcal Vaccine for Pediatric Patients This blog post is part of a series highlighting essential changes in the 2024 ACIP immunization schedules. This series is written alongside Immunization Program Medical Specialist, Dr. Mayssa Abuali. Dr. Abuali is board-certified in general pediatrics, pediatric infectious diseases, and pediatric hospital...
Administration Errors: RSV for Infants On November 30, CDC alerted immunization programs that they have received reports of infants being mistakenly administered RSV vaccines intended for adults. Infants should only receive the RSV preventive antibody, nirsevimab (Beyfortus, Sanofi).RSV vaccines (Arexvy by GSK and Abrysvo by Pfizer) are...
Quality Improvement Opportunity for VFC Providers The Immunization Quality Improvement for Providers (IQIP) Program is a CDC initiative to help providers implement strategies that support their immunization activities. VFC-enrolled practices are chosen by the CDC for IQIP enrollment each year. However, starting this project year (July 1, 2023 to...
Vaccine Shipment Delays During the December Holiday Submit orders by Friday, December 8! During the holiday season – from mid-December to early January – the distribution center that ships vaccine provided through the Vaccines for Children (VFC), Vaccines for Adults at Risk (VFAAR), and Bridge Access programs...
Nirsevimab (Beyfortus) Updates Due to the unprecedented demand for nirsevimab, supply of this product is extremely limited through both the Vaccines for Children (VFC) program and the private market. Below is an update on available supply and tips on how to prioritize use of available doses....
Pneumococcal Vaccination for Asthmatic Pediatric Patients This blog post is part of a series highlighting important changes in the 2024 ACIP immunization schedules. This series is written alongside newly onboarded Immunization Program Medical Specialist, Dr. Mayssa Abuali. Dr. Abuali is board certified in general pediatrics, pediatric infectious...
